Fuzuloparib Capsules (brand name:艾瑞颐) is a prescription medication primarily indicated for the treatment of specific types of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The following are important guidelines for the purchase and use of this medication:
Purchase Channels
Fuzuloparib Capsules can be obtained through the following authorized and legitimate channels:
Hospital Pharmacy
Available for direct dispensing at the hospital pharmacy, upon a prescription issued by an oncology or gynecology outpatient clinic.
Physical Pharmacies
Licensed retail pharmacies or large chain pharmacies, requiring a valid doctor’s prescription.
Certified Online Pharmacies
Platforms holding the Internet Drug Information Service Qualification Certificate, Drug Operation License, and Internet Drug Trading Service Qualification Certificate.
Key Precautions
Prescription-only Purchase
Fuzuloparib is a prescription-only medicine; a formal prescription issued by a licensed physician is mandatory for purchase. Some certified online pharmacies offer online consultation services, where a practicing physician may issue a prescription after clinical evaluation.
Verification of Drug Authenticity
Check the drug packaging, approval number, and manufacturer information before purchase.
Do not purchase from unregulated channels such as social media, personal agents, or informal suppliers to avoid counterfeit or substandard products.
Storage and Expiry Date
Store the medication as instructed (typically in a cool, dry place) and use it before the expiry date. Expired medication must not be taken.
Medication Safety Advice
Professional Supervision
This product must be used under the guidance of a physician experienced in oncological treatment. Do not adjust the dosage or discontinue treatment without medical approval.
Contraindications and Monitoring
Women of childbearing potential must use effective contraception during treatment and for 6 months after the last dose.
Blood routine tests are required before treatment and during the initial phase (recommended every 2 weeks for the first 3 months), as the drug may cause hematological toxicities including anemia and leukopenia.
Avoid driving or operating machinery if severe fatigue, dizziness, or related symptoms occur.
Management of Adverse Reactions
If persistent or worsening discomfort develops during treatment, seek immediate medical attention.
Important Reminder
Fuzuloparib is an antineoplastic (anti-tumor) drug. Its use must strictly comply with medical instructions. All decisions regarding purchase and administration should be based on professional medical advice.
